Siti Sanaa Wan Azman Norlela Sukor Muhammad Yusuf Abu Shamsi Ilham Ismail Nor Azmi Kamaruddin
10.3389/fendo.2022.867647
Front Endocrinol (Lausanne)
2022 May 30;13:867647.
sglt2 inhibitor sglt2 inhibitor-induced diabetic ketoacidosis diabetic ketoacidosis euglycemic diabetic ketoacidosis high-calorie glucose
CC BY
https://pubmed.ncbi.nlm.nih.gov/35712244/
Diabetes Mellitus Diabetic Ketoacidosis / chemically induced Diabetic Ketoacidosis / drug therapy Sodium-Glucose Transporter 2 Inhibitors / adverse effects
Diabetes Mellitus Diabetic Ketoacidosis / chemically induced Diabetic Ketoacidosis / drug therapy Sodium-Glucose Transporter 2 Inhibitors / adverse effects Case Reports Benzhydryl Compounds Glucose Glucosides / therapeutic use Glycemic Control Humans Benzhydryl Compounds Glucosides Sodium-Glucose Transporter 2 Inhibitors empagliflozin Glucose
PMC9197436
35712244
Case Report: High-Calorie Glucose Infusion and Tight Glycemic Control in Ameliorating Refractory Acidosis of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis
2022